• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Renal excretion of vancomycinin in kidney disease.

作者信息

Nielsen H E, Hansen H E, Korsager B, Skov P E

出版信息

Acta Med Scand. 1975 Apr;197(4):261-4. doi: 10.1111/j.0954-6820.1975.tb04914.x.

DOI:10.1111/j.0954-6820.1975.tb04914.x
PMID:1136852
Abstract

The renal climination of vancomycin has been determined in 18 patients. In 4 anuric patients in intermittent haemodialysis the dosage of vancomycin necessary to treat infection with penicillin-resistantstrains of Staphylococcus aureus was determined. In 14 patients with varying degrees of renal insufficiency vancomycin, creatinine and 125-iothalamate clearances were measured and found to be closely correlated. After administration of the initial vancomycin dose and attainment of the serum concentration desired, the maintenance dose can be calculated on the basis of the GFR.

摘要

相似文献

1
Renal excretion of vancomycinin in kidney disease.
Acta Med Scand. 1975 Apr;197(4):261-4. doi: 10.1111/j.0954-6820.1975.tb04914.x.
2
Estimation of glomerular filtration rate to adjust vancomycin dosage in critically ill patients: superiority of the Chronic Kidney Disease Epidemiology Collaboration equation?估算肾小球滤过率以调整重症患者万古霉素剂量:慢性肾脏病流行病学合作组织方程的优势?
Anaesth Intensive Care. 2014 Mar;42(2):178-84. doi: 10.1177/0310057X1404200203.
3
Application of vancomycin in patients with varying renal function, especially those with augmented renal clearance.万古霉素在不同肾功能患者中的应用,尤其是那些肾脏清除率增加的患者。
Pharm Biol. 2016 Dec;54(12):2802-2806. doi: 10.1080/13880209.2016.1183684. Epub 2016 Jun 1.
4
Pharmacokinetics of vancomycin in anuria.万古霉素在无尿症中的药代动力学。
Rev Infect Dis. 1981 Nov-Dec;3 suppl:S269-72.
5
[Measurements of vancomycin concentrations in the blood - a method of personalization the antibiotic therapy in patients with chronic kidney disease].[血液中万古霉素浓度的测定——一种使慢性肾病患者抗生素治疗个体化的方法]
Pol Merkur Lekarski. 2017 Apr 21;42(250):145-150.
6
[Thyroxine therapy in chronic renal insufficiency].[慢性肾功能不全中的甲状腺素治疗]
Monatsschr Kinderheilkd (1902). 1971 Jun;119(6):213-8.
7
[Diuretics in reduced kidney function].[肾功能减退时的利尿剂]
Internist (Berl). 1971 Aug;12:Suppl:345-51.
8
Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.血清胱抑素C用于在调整阿米卡星、庆大霉素、妥布霉素和万古霉素剂量时预测肾小球滤过率。
Ther Drug Monit. 2006 Jun;28(3):326-31. doi: 10.1097/01.ftd.0000211805.89440.3d.
9
Glomerular filtration rate equations do not accurately predict vancomycin trough concentrations in pediatric patients.肾小球滤过率方程不能准确预测儿科患者的万古霉素谷浓度。
Ann Pharmacother. 2014 Jun;48(6):691-6. doi: 10.1177/1060028014527908. Epub 2014 Mar 19.
10
Pharmacokinetics of vancomycin when administered during high flux hemodialysis.高通量血液透析期间给予万古霉素的药代动力学。
Clin Nephrol. 1998 Jul;50(1):51-5.

引用本文的文献

1
Identification of Patients Who Require Two-Point Blood Sampling for the Peak and Trough Values Rather Than One-Point Blood Sampling for the Trough Value for the Evaluation of AUC of Vancomycin Using Bayesian Estimation.采用贝叶斯估计评估万古霉素 AUC 时,确定需要两点采血(峰和谷)而不是单点采血(仅谷值)的患者。
Pharm Res. 2024 Nov;41(11):2161-2171. doi: 10.1007/s11095-024-03781-4. Epub 2024 Oct 21.
2
A Meta-Analysis on the Performance of Cystatin C- versus Creatinine-based eGFR Equations in Predicting Vancomycin Clearance.胱抑素 C 与基于肌酐的 eGFR 方程预测万古霉素清除率的性能的荟萃分析。
J Korean Med Sci. 2020 Sep 21;35(37):e306. doi: 10.3346/jkms.2020.35.e306.
3
Vancomycin-Induced Kidney Injury: Animal Models of Toxicodynamics, Mechanisms of Injury, Human Translation, and Potential Strategies for Prevention.
万古霉素相关性肾损伤:毒代动力学动物模型、损伤机制、人体转化及潜在的预防策略。
Pharmacotherapy. 2020 May;40(5):438-454. doi: 10.1002/phar.2388. Epub 2020 May 4.
4
Vancomycin Resistance Is Overcome by Conjugation of Polycationic Peptides.黏菌素耐药性通过阳离子肽的共轭而被克服。
Angew Chem Int Ed Engl. 2020 Jun 2;59(23):8823-8827. doi: 10.1002/anie.202002727. Epub 2020 Apr 21.
5
Evaluation of the Safety of a Vancomycin Nomogram Used to Achieve Target Trough Concentrations.用于达到目标谷浓度的万古霉素剂量图表的安全性评估。
Hosp Pharm. 2015 Nov;50(10):900-910. doi: 10.1310/hpj5010-900. Epub 2015 Nov 19.
6
Prospective trial of a novel nomogram to achieve updated vancomycin trough concentrations.一项用于实现更新万古霉素谷浓度的新型列线图的前瞻性试验。
Interdiscip Perspect Infect Dis. 2013;2013:839456. doi: 10.1155/2013/839456. Epub 2013 Sep 12.
7
Vancomycin: pharmacokinetics and administration regimens in neonates.万古霉素:新生儿的药代动力学及给药方案
Clin Pharmacokinet. 2004;43(7):417-40. doi: 10.2165/00003088-200443070-00001.
8
Clinical review: use of vancomycin in haemodialysis patients.临床综述:万古霉素在血液透析患者中的应用
Crit Care. 2002 Aug;6(4):313-6. doi: 10.1186/cc1516. Epub 2002 Jun 10.
9
Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique.采用贝叶斯预测技术测定肥胖对万古霉素药代动力学参数的影响。
Antimicrob Agents Chemother. 1993 Mar;37(3):436-40. doi: 10.1128/AAC.37.3.436.
10
Pharmacokinetic optimisation of vancomycin therapy.万古霉素治疗的药代动力学优化
Clin Pharmacokinet. 1995 Apr;28(4):327-42. doi: 10.2165/00003088-199528040-00005.